Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

This Could Be the Next Big Pot Stock
This Could Be the Next Big Pot Stock

Pot stocks are a dime a dozen these days. There is no shortage of companies out there touting that their cannabis is higher quality than their peers. For investors, it makes investing in a cannabis

Is Momo Still an Undervalued Growth Stock?
Is Momo Still an Undervalued Growth Stock?

Momo's (NASDAQ: MOMO) stock recently dipped after the Chinese tech company posted its first-quarter earnings. Its revenue dipped 3.5% annually to 3.59 billion yuan ($507.6 million), beating

Why Vista Outdoor Stock Popped 23% This Morning
Why Vista Outdoor Stock Popped 23% This Morning

Shares of ammunition and outdoor sporting goods manufacturer Vista Outdoor (NYSE: VSTO) spiked 23% higher as Monday trading began, although the stock has since retraced to about a 12% gain as of

Europe Rules Nestle’s Plant-Based Incredible Burger Too Similar to Impossible Burger
Europe Rules Nestle’s Plant-Based Incredible Burger Too Similar to Impossible Burger

As impossible as it sounds, Nestle (OTC: NSRGY) has lost a European trademark infringement case to Impossible Foods over its plant-based burgers.

The District Court of The Hague in the Netherlands

Here's Why Intellia Therapeutics Gained as Much as 18.0% TodayPhoto, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
Here's Why Intellia Therapeutics Gained as Much as 18.0% Today

Shares of Intellia Therapeutics (NASDAQ: NTLA) rose as much as 18% today after the company announced an expansion of its partnership with Regeneron Pharmaceuticals (NASDAQ: REGN)

The pair will

1 High-Yield Stock to Buy This June
1 High-Yield Stock to Buy This June

This year has been an awful one for dividend investors due to the economic fallout from the COVID-19 pandemic. More than 175 public companies have cut their payouts by at least 50%, with several

Analyst Upgrades Keurig Dr Pepper to Outperform
Analyst Upgrades Keurig Dr Pepper to Outperform

Keurig Dr Pepper (NYSE: KDP) is off to a strong start after reporting robust sales growth in its first quarter and the likelihood that it will continue as the economy reopens. Robert Ottenstein at

Why Diversified Healthcare Trust Jumped 10% This MorningPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Why Diversified Healthcare Trust Jumped 10% This Morning

Shares of healthcare-focused real estate investment trust (REIT) Diversified Healthcare Trust (NASDAQ: DHC) rose 10% out of the gate on June 1. That came after strong gains in the previous week. The

Why Gap Stock Is Trading Higher Today
Why Gap Stock Is Trading Higher Today

Shares of Gap (NYSE: GPS) were moving higher on Monday, after a key analyst raised his price target and upgraded the stock.

As of 10:45 a.m. EDT today, Gap's shares were up 14.4% from Friday's

Why Facebook Has a Better Shot at E-Commerce This Time
Why Facebook Has a Better Shot at E-Commerce This Time

"Been there, done that unsuccessfully." That's what some investors may be thinking about Facebook's (NASDAQ: FB) new e-commerce push. The tech stock has made online shopping missteps in the past

Is Catalent a Buy?Photo, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Is Catalent a Buy?

The world's pharma and biopharma companies are sprinting to develop hundreds of treatments for COVID-19 and vaccines for SARS-CoV-2. Almost half of those have been pitched to drug manufacturer

Like Dividends? You'll Love These 5 Stocks
Like Dividends? You'll Love These 5 Stocks

Picking the best dividend stocks to add to your investment portfolio requires more than looking for the highest yields. For years of dependable dividend income, you need to find well-run companies

3 Biotech Quick Picks to Invest $5,000 This WeekPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
3 Biotech Quick Picks to Invest $5,000 This Week

Building a balanced portfolio of healthcare stocks requires investing in safer and more mature companies as well as riskier upstarts to drive long-term growth. Between Gilead Sciences (NASDAQ: GILD)

Zynga to Spend $1.8 Billion to Acquire Peak
Zynga to Spend $1.8 Billion to Acquire Peak

Zynga (NASDAQ: ZNGA) is spending $1.8 billion to acquire Peak, the Turkish mobile gaming company behind Toon Blast and Toy Blast, for $1.8 billion. 

In a press release announcing the acquisition

Why You Need North American Railroads
Why You Need North American Railroads

In this episode of Industry Focus: Energy, Nick Sciple chats with Fool.com contributor Lou Whiteman about the railroad industry. They provide an overview of the railroad industry, the major players

How the Financial Solvency of Employers Affects a 401(k)
How the Financial Solvency of Employers Affects a 401(k)

In this episode of Motley Fool Answers, Alison Southwick, Motley Fool personal finance expert Robert Brokamp, and Fool.com contributor Dan Caplinger answer listeners' questions about backdoor Roth

Gilead Reports Positive Late-Stage Study Results for Remdesivir in Patients With Moderate COVID-19Photo, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Gilead Reports Positive Late-Stage Study Results for Remdesivir in Patients With Moderate COVID-19

On Monday, Gilead Sciences (NASDAQ: GILD) announced results from a phase 3 clinical trial evaluating remdesivir in treating hospitalized patients with moderate cases of COVID-19. The company stated

2 Best Biotech Stocks to Buy Right NowPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png
2 Best Biotech Stocks to Buy Right Now

When it comes to biotech stocks, the recent focus has been on companies working on coronavirus treatments or prevention. While it's fine to jump on that bandwagon, there are other biotech investment

Is This Chinese E-Sports Stock Still Worth Buying?
Is This Chinese E-Sports Stock Still Worth Buying?

DouYu International (NASDAQ: DOYU), one of the top video game and live streaming platforms in China, went public nearly a year ago at $11.50 per share. However, DouYu didn't dazzle investors as much

Is Ulta Beauty Stock Headed Back Down to $230?Photo, wide shot, wide-angle lens,  Clothing manufacturer, neutral atmosphere, photo by Galina Stepanova: https://img.theapi.app/temp/4c710447-f68a-47bc-a682-c2d83e801596.png
Is Ulta Beauty Stock Headed Back Down to $230?

Ulta Beauty (NASDAQ: ULTA) has attracted another conflicted Wall Street pro. An analyst at Loop Capital this week boosted his price target on the retailer's stock while keeping his rating at a hold

Low-Price Retailers Post High GrowthPhoto, wide shot, wide-angle lens,  Fashion store, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.theapi.app/temp/4103ce22-87d6-4bef-ba44-0baf5ab280bb.png
Low-Price Retailers Post High Growth

In this episode of MarketFoolery, Chris Hill chats with Fool.com contributor Dan Kline about the latest news from the markets. They look at the retail space and how retail businesses are serving

Netflix Makes a Smart Move in Its Quest for 100 Million Subscribers
Netflix Makes a Smart Move in Its Quest for 100 Million Subscribers

The novel coronavirus pandemic has been a source of economic despair across the globe as people have been forced to remain at home to contain the spread. But entertainment seekers looking for

Only 23% of Older Workers Are Considering This Smart Social Security Strategy
Only 23% of Older Workers Are Considering This Smart Social Security Strategy

Millions of retirees depend on Social Security benefits to make ends meet during their senior years. The average Social Security recipient receives just over $1,500 per month in benefits, and nearly